<DOC>
	<DOCNO>NCT01532726</DOCNO>
	<brief_summary>This multicenter , non-interventional , prospective study . The observation period comprise least 6 month , initiation ESL add-on therapy adult patient partial-onset epilepsy sufficiently control one AED , first visit occur 6 9 month follow-up . The observation period end 9 month follow-up even final assessment perform .</brief_summary>
	<brief_title>Eslicarbazepine Acetate Add-On Treatment One Baseline Antiepileptic Drug ( ESLADOBA )</brief_title>
	<detailed_description>To ensure non-interventional status , neurologist 's decision patient 's best interest prescribe adjunctive ESL make independently his/her decision include patient study . At circumstance study patient treat follow accord routine clinical practice . ESL concomitant medication manage neurologist accord respective Summary Product Characteristics ( SPC ) .In order reflect real-life practice ensure observational nature study , fix time-points study assessment define . Intermediate follow-up data collect whenever patient attend study 's neurologist consultation .</detailed_description>
	<mesh_term>Eslicarbazepine acetate</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Male female outpatient , 18 year old ; The patient establish diagnosis epilepsy experience least one partialonset seizure , without secondary generalization , within four week prior initiation adjunctive ESL ; The patient sufficiently control current antiepileptic monotherapy , neurologist clinical judgment , patient 's best interest prescribe adjunctive ESL ; The neurologist 's decision prescribe ESL make independently his/her decision include patient study ; The patient 's treatment accordance SPC ESL ; Written inform consent patient ( legally acceptable representative , subject unable provide inform consent ) . Known hypersensitivity active substance , carboxamide derivative ( e.g . oxcarbazepine carbamazepine ) excipients ; Patient 2nd 3rd degree atrioventricular block ; Patient treat experimental drug within four week prior introduction ESL ; Female patient pregnant , lactate , plan become pregnant study period ; Patient start ESL outside approve SPC enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Partial-Onset Seizures</keyword>
	<keyword>Eslicarbazepine Acetate</keyword>
	<keyword>ESL</keyword>
	<keyword>BIA 2-093</keyword>
	<keyword>BIAL</keyword>
</DOC>